(Q28256132)

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

volume

13

0 references

issue

1

0 references

page(s)

24-34

0 references

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Liver, gallbladder, extrahepatic bile ducts, and pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Cytological differentiation of asymptomatic pancreatic islet cell tumours in autopsy material

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

The APUD concept and hormone production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Synaptophysin: a marker protein for neuroendocrine cells and neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Non-islet origin of pancreatic islet cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Hereditary pancreatic endocrine tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

EUS is still superior to multidetector computerized tomography for detection of pancreatic neuroendocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Localization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: the NIH experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Importance of hospital volume in the overall management of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Update on the management of neuroendocrine hepatic metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Laparoscopic radiofrequency thermal ablation of neuroendocrine hepatic metastases: long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Radioembolization of liver tumors with yttrium-90 microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Percutaneous hepatic perfusion in patients with metastatic liver cancer: anesthetic, hemodynamic, and metabolic considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Activity of sunitinib in patients with advanced neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Everolimus for advanced pancreatic neuroendocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

ADENOMA OF ISLET CELLS WITH HYPERINSULINISM: A REVIEW.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Surgical treatment of insulinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Anatomic distribution of pancreatic endocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0172-2

Neuron-specific enolase is produced by neuroendocrine tumours

21 January 2018

1 reference

12 December 2020

Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell Carcinoma

1 reference

12 December 2020

Localization of Pancreatic Endocrine Tumors by Endoscopic Ultrasonography

1 reference

12 December 2020

Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis

1 reference

12 December 2020

Insulinomas: localization with selective intraarterial injection of calcium

1 reference

12 December 2020

Concurrent resections of pancreatic islet cell cancers with synchronous hepatic metastases: outcomes of an aggressive approach

1 reference

12 December 2020

Insulin-producing islet cell tumors.

1 reference

12 December 2020

Detection of chromogranin in neuroendocrine cells with a monoclonal antibody

1 reference

12 December 2020